Q2 2026 Holdings
Filed 2026-08-12 | 23 holdings | $507.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-08-13) | View on SEC ↗ · Holdings Table ↗
This amendment's correction looks implausible relative to the firm's filing history and is under review — showing the original filing's data below instead.
Lynx1 Capital Advisors LLC: Sub-manager's reported value grew 70.5% versus the original filing (from $507.6M to $865.5M), and now represents 170.5% of the firm's original firm-wide total ($507.6M) — flagged for manual review before treating this correction as reliable.
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $163.2M | 8,963,500 | 32.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $132.1M | 4,038,404 | 26.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $126.5M | 3,408,937 | 24.9% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $34.2M | 7,326,691 | 6.7% |
| Korro BIO Inc(KRRO) |
| COM |
| 500946108 |
| $20.3M |
| 1,538,296 |
| 4.0% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $7.9M | 8,019,148 | 1.5% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $7.5M | 950,466 | 1.5% |
| Neuphoria Therapeutics Inc(NEUP) | COM | 64136E102 | $3.8M | 875,328 | 0.8% |
| Passage BIO Inc(PASG) | COM NEW | 702712209 | $3.3M | 673,759 | 0.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $2.2M | 31,391 | 0.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.0M | 1,798,070 | 0.4% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $1.3M | 178,606 | 0.3% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.1M | 1,628,700 | 0.2% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $471.8K | 559,470 | 0.1% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $300.5K | 61,588 | 0.1% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $299.8K | 11,658 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $292.9K | 18,194 | 0.1% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $236.7K | 657,786 | 0.0% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $186.6K | 10,100 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT) | COM NEW | 097702203 | $118.6K | 30,800 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $91.0K | 16,029 | 0.0% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $66.1K | 10,000 | 0.0% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $40.6K | 20,000 | 0.0% |